10-QPeriod: Q2 FY2025

ECOLAB INC. Quarterly Report for Q2 Ended Jun 30, 2025

Filed August 7, 2025For Securities:ECL

Summary

Ecolab Inc. (ECL) reported solid financial results for the second quarter and first six months of 2025. Net sales saw a modest increase of 1% year-over-year, reaching $4,025.2 million for the quarter, with organic sales up 3%. This growth was driven by increases across most of its reporting segments, including Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences, underscoring the company's ability to maintain pricing power and expand its market reach. Profitability showed a notable improvement, with reported operating income increasing by 8% to $710.1 million for the quarter. Net income attributable to Ecolab rose by 7% to $524.2 million. The company also highlighted strong performance in adjusted metrics, with adjusted diluted EPS increasing by 13% to $1.89, reflecting effective cost management and operational efficiencies, particularly from the 'One Ecolab' initiative. The balance sheet remains robust, with a strong cash position and manageable debt levels, supporting ongoing capital expenditures and shareholder returns.

Financial Statements
Beta

Key Highlights

  • 1Net sales increased 1% to $4,025.2 million in Q2 2025, with organic sales up 3%, demonstrating continued revenue growth.
  • 2Reported operating income increased 8% to $710.1 million, and net income attributable to Ecolab rose 7% to $524.2 million, indicating improved profitability.
  • 3Adjusted diluted EPS increased by a strong 13% to $1.89, showcasing effective cost management and operational efficiency gains.
  • 4The 'One Ecolab' initiative continues to contribute positively, with ongoing restructuring efforts expected to enhance growth and margin expansion.
  • 5Global Water segment organic sales increased 2%, driven by strong performance in Food & Beverage and Light & Heavy, indicating resilience in key industrial markets.
  • 6The company maintained a strong liquidity position with $1,920.9 million in cash and cash equivalents as of June 30, 2025.
  • 7Long-term debt was $7,522.2 million as of June 30, 2025, with the company managing its debt profile effectively, including the issuance of new notes and subsequent repayment of a significant portion of existing debt shortly after the quarter end.

Frequently Asked Questions

Sales growth in the second quarter was driven by a combination of volume increases and effective value pricing across Ecolab's key segments. Organic sales growth of 3% reflects continued demand for its products and services in critical markets like Food & Beverage, Light & Heavy industries, and Healthcare.

The 'One Ecolab' initiative is contributing to improved operational efficiencies and margin expansion. The company recorded restructuring charges and special charges related to this initiative, which are expected to yield annualized cost savings. Excluding these charges and discrete tax items, adjusted net income and adjusted diluted EPS showed significant year-over-year increases, highlighting the underlying strength of the business.

Ecolab maintains a strong financial position. As of June 30, 2025, the company had $1,920.9 million in cash and cash equivalents. Total debt was $8,207.9 million, but the company's net debt to EBITDA ratio remained healthy at 1.6. The company has sufficient liquidity to fund its operations, capital expenditures, and shareholder returns.

The company operates in a dynamic global economic environment with risks including evolving international trade policies, foreign currency fluctuations, and potential supply chain challenges. Specific litigation matters, such as the TPC Group litigation, are also ongoing, though the company believes its potential losses are manageable or covered by insurance. Management is actively assessing the impact of new tax legislation like the 'One Big Beautiful Bill Act'.